Elicio Therapeutics Stock Price To Book
| ELTX Stock | 4.23 0.24 6.02% |
Elicio Therapeutics fundamentals help investors to digest information that contributes to Elicio Therapeutics' financial success or failures. It also enables traders to predict the movement of Elicio Stock. The fundamental analysis module provides a way to measure Elicio Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Elicio Therapeutics stock.
Price To Book Ratio is likely to rise to 3.89 in 2024. Elicio | Price To Book |
Elicio Therapeutics Company Price To Book Analysis
Elicio Therapeutics' Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Elicio Therapeutics Price To Book | 10.11 X |
Most of Elicio Therapeutics' fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Elicio Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Elicio Price To Book Driver Correlations
Understanding the fundamental principles of building solid financial models for Elicio Therapeutics is extremely important. It helps to project a fair market value of Elicio Stock properly, considering its historical fundamentals such as Price To Book. Since Elicio Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Elicio Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Elicio Therapeutics' interrelated accounts and indicators.
Click cells to compare fundamentals
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Elicio Book Value Per Share
Book Value Per Share |
|
Based on the latest financial disclosure, Elicio Therapeutics has a Price To Book of 10.1068 times. This is 60.64% lower than that of the Pharmaceuticals sector and 67.33% higher than that of the Health Care industry. The price to book for all United States stocks is 6.28% lower than that of the firm.
Elicio Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Elicio Therapeutics' direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Elicio Therapeutics could also be used in its relative valuation, which is a method of valuing Elicio Therapeutics by comparing valuation metrics of similar companies.Elicio Therapeutics is currently under evaluation in price to book category among its peers.
Elicio Therapeutics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Elicio Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Elicio Therapeutics' managers, analysts, and investors.Environmental | Governance | Social |
Elicio Fundamentals
| Return On Equity | -3.53 | ||||
| Return On Asset | -0.97 | ||||
| Current Valuation | 48.25 M | ||||
| Shares Outstanding | 10.77 M | ||||
| Shares Owned By Insiders | 28.13 % | ||||
| Shares Owned By Institutions | 6.08 % | ||||
| Number Of Shares Shorted | 43.04 K | ||||
| Price To Book | 10.11 X | ||||
| EBITDA | (34.58 M) | ||||
| Net Income | (35.2 M) | ||||
| Total Debt | 6.92 M | ||||
| Book Value Per Share | (0.16) X | ||||
| Cash Flow From Operations | (32.69 M) | ||||
| Short Ratio | 1.92 X | ||||
| Earnings Per Share | 0.92 X | ||||
| Target Price | 10.0 | ||||
| Number Of Employees | 32 | ||||
| Market Capitalization | 45.58 M | ||||
| Total Asset | 27.15 M | ||||
| Retained Earnings | (142.2 M) | ||||
| Working Capital | 6.58 M | ||||
| Net Asset | 27.15 M |
About Elicio Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Elicio Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Elicio Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Elicio Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Elicio Stock Analysis
When running Elicio Therapeutics' price analysis, check to measure Elicio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elicio Therapeutics is operating at the current time. Most of Elicio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Elicio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elicio Therapeutics' price. Additionally, you may evaluate how the addition of Elicio Therapeutics to your portfolios can decrease your overall portfolio volatility.